Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy
European Journal of Immunology · 2024
DOI: 10.1002/eji.202451093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Han Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Neoplasms, Cellular Senescence, Immunotherapy, Tumor Microenvironment. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: National Key R&D Program: Intergovernmental International Science and Technology Innovation Cooperation Project, National Natural Science Foundation of China, Henan Province Medical Science and Technology Research Province and Ministry Co-constructed Projects.
Abstract (Originalsprache)
Immunosenescence, the aging of the immune system, leads to functional deficiencies, particularly in T cells, which undergo significant changes. While numerous studies have investigated age‐related T‐cell phenotypes in healthy aging, senescent T cells have also been observed in younger populations during pathological conditions like cancer. This review summarizes the recent advancements in age‐associated alterations and markers of T cells, mechanisms, and the relationship between senescent T cells and the tumor microenvironment. We also discuss potential strategies for targeting senescent T cells to prevent age‐related diseases and enhance tumor immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan, China.
- Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
ORCID-Profile: Yi Zhang
Förderung
- National Key R&D Program: Intergovernmental International Science and Technology Innovation Cooperation Project
- National Natural Science Foundation of China
- Henan Province Medical Science and Technology Research Province and Ministry Co-constructed Projects
- Henan Provincial Central Leading Local Science and Technology Development Fund Project
- Science and Technology Project of Henan Province
Zitieren
APA
Wu, H., Li, J., Zhang, Z., & Zhang, Y. (2024). Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy. European Journal of Immunology. https://doi.org/10.1002/eji.202451093
Vancouver
Wu H, Li J, Zhang Z, Zhang Y. Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy. European Journal of Immunology. 2024. doi:10.1002/eji.202451093
BibTeX
@article{Wu2024,
author = {Wu, Han and Li, Junru and Zhang, Zhen and Zhang, Yi},
title = {Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202451093}
}
EUVIMED